Leveraging existing data for prioritization of the ecological risks of human and veterinary pharmaceuticals to aquatic organisms

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 369, Issue 1656, 2014, Pages

  LaLone, Carlie A ^a,b   Berninger, Jason P ^c   Villeneuve, Daniel L ^b   Ankley, Gerald T ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c NATIONAL RESEARCH COUNCIL   (United States)

Author keywords

Adverse outcome pathway; Molecular target conservation; Pharmacokinetics; Read across; SeqAPASS

Indexed keywords

AQUATIC COMMUNITY; DRUG DEVELOPMENT; ENVIRONMENTAL MONITORING; POLLUTION EXPOSURE; PRIORITIZATION;

DRUG; WATER POLLUTANT;

ANIMAL; AQUATIC SPECIES; CHEMISTRY; DRUG EFFECTS; HUMAN; RISK FACTOR; SPECIES DIFFERENCE; TOXICITY; WATER POLLUTANT;

ANIMALS; AQUATIC ORGANISMS; HUMANS; PHARMACEUTICAL PREPARATIONS; RISK FACTORS; SPECIES SPECIFICITY; WATER POLLUTANTS, CHEMICAL;

EID: 84907821700     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2014.0022     Document Type: Review

References (92)

1. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT. 2002 Pharmaceuticals, hormones, and other organic wastewater contaminants in U. S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36, 1202-1211. (doi: 10. 1021/es011055j).
2. Purdom CE, Hardiman PA, Bye VJ, Eno NC, Tyer CR, Sumpter JP. 1994 Estrogenic effects of effluents from sewage treatment works. Chem. Ecol. 8, 275-285. (doi: 10. 1080/02757549408038554).
3. Oaks JL et al. 2004 Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427, 630-633. (doi: 10. 1038/nature02317).
4. Daughton CG, Brooks BW. 2011 Environmental contaminants in biota. New York, NY: CRC Press.
5. Ankley GT, Brooks BW, Huggett DB, Sumpter JP. 2007 Repeating history: pharmaceuticals in the environment. Environ. Sci. Technol. 41, 8211-8217. (doi: 10. 1021/es072658j).
6. Brain RA, Brooks BW. 2012 Considerations and criteria for the incorporation of mechanistic sublethal endpoints into environmental risk assessment for biologically active compounds. In Human pharmaceuticals in the environment, current and future perspectives, ch. 7, pp. 139-165. New York, N: Springer Science þ Business Media, LLC.
7. Lin JH, Lu AY. 1997 Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol. Rev. 49, 403-449.
8. Arnold KE et al. 2013 Assessing the exposure risk and impacts of pharmaceuticals in the environment on individuals and ecosystems. Biol. Lett. 9, 20130492. (doi: 10. 1098/rsbl. 2013. 0492).
9. Knox C et al. 2011 DrugBank 3. 0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 39, D1035-D1041. (doi: 10. 1093/nar/gkq1126).
10. Boxall ABA et al. 2012 Pharmaceuticals and personal care products in the environment: what are the big questions? Environ. Health Perspect. 120, 1221-1229. (doi: 10. 1289/ehp. 1104477).
11. Kostich MS, Lazorchak JM. 2008 Risks to aquatic organisms posed by human pharmaceutical use. Sci. Total Environ. 389, 329-339. (doi: 10. 1016/j. scitotenv. 2007. 09. 008).
12. Roos V, Gunnarsson L, Fick J, Larsson DG, Ruden C. 2012 Prioritising pharmaceuticals for environmental risk assessment: towards adequate and feasible first-tier selection. Sci. Total Environ. 421-422, 102-110. (doi: 10. 1016/j. scitotenv. 2012. 01. 039).
13. Caldwell DJ, Mastrocco F, Hutchinson TH, Lange R, Heijerick D, Janssen C, Anderson PD, Sumpter JP. 2008 Derivation of an aquatic predicted no-effect concentration for the synthetic hormone, 17a-ethinyl estradiol. Environ. Sci. Technol. 42, 7046-7054. (doi: 10. 1021/es800633q).
14. LaLone CA et al. 2013 Molecular target sequence similarity as a basis for species extrapolation to assess the ecological risk of chemicals with known modes of action. Aquat. Toxicol. 144-145, 141-154. (doi: 10. 1016/j. aquatox. 2013. 09. 004).
15. Ankley GT, Gray LE. 2013 Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals. Environ. Toxicol. Chem. 32, 1084-1087. (doi: 10. 1002/etc. 2151).
16. Cao D, Wang J, Zhou R, Li Y, Yu H, Hou T. 2012 ADMET evaluation in drug discovery. 11. Pharmacokinetics knowledge base (PKKB): a comprehensive database of pharmacokinetic and toxic properties for drugs. J. Chem. Inf. Model. 52, 1132-1137. (doi: 10. 1021/ci300112j).
17. Moda TL, Torres LG, Carrara AE, Andricopulo AD. 2008 PK/DB: database for pharmacokinetic properties and predictive in silico ADME models. Bioinformatics 24, 2270-2271. (doi: 10. 1093/bioinformatics/btn415).
18. Obach RS, Lombardo F, Waters NJ. 2008 Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab. Dispos. 36, 1385-1405. (doi: 10. 1124/dmd. 108. 020479).
19. Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. 2012 Therapeutic and toxic blood concentrations of nearly 1, 000 drugs and other xenobiotics. Crit. Care 16, R136. (doi: 10. 1186/cc11441).
20. Anon. 2013 Physicians desk reference, 67th edn. Montvale, NJ: PDR Network.
21. Rand-Weaver M, Margiotta-Casaluci L, Patel A, Panter GH, Owen SF, Sumpter JP. 2013 The readacross hypothesis and environmental risk assessment of pharmaceuticals. Environ. Sci. Technol. 47, 11 384-11 395. (doi: 10. 1021/es402065a).
22. Berninger JP, Brooks BW. 2010 Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. Toxicol. Lett. 193, 69-78. (doi: 10. 1016/j. toxlet. 2009. 12. 006).
23. Gunnarsson L, Jauhiainen A, Kristiansson E, Nerman O, Larsson DG. 2008 Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ. Sci. Technol. 42, 5807-5813. (doi: 10. 1021/es8005173).
24. LaLone CA et al. 2013 Cross species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactone. Environ. Toxicol. Chem. 32, 2528-2541. (doi: 10. 1002/etc. 2330).
25. Walker SD, McEldowney S. 2013 Molecular docking: a potential tool to aid ecotoxicity testing in environmental risk assessment of pharmaceuticals. Chemosphere 93, 2568-2577. (doi: 10. 1016/j. chemosphere. 2013. 09. 074).
26. McRobb FM, Sahagun V, Kufareva I, Abagyan R. 2014 In silico analysis of the conservation of human toxicity and endocrine disruption targets in aquatic species. Environ. Sci. Technol. 48, 1964-1972. (doi: 10. 1021/es404568a).
27. Ankley GT et al. 2010 Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 29, 730-741. (doi: 10. 1002/etc. 34).
28. Miyagawa S et al. 2014 Differing species responsiveness of estrogenic contaminants in fish is conferred by the ligand binding domain of the estrogen receptor. Environ. Sci. Technol. 48, 5254-5263. (doi: 10. 1021/es5002659).
29. Organisation of Economic Cooperation and Development. 2014 Adverse outcome pathways, molecular screening and toxicogenomics. http://www. oecd. org/chemicalsafety/testing/adverseoutcome-pathways-molecular-screening-andtoxicogenomics. htm (accessed 31 March 2014).
30. Ankley GT et al. 2003 Effects of the androgenic growth promoter 17-b-trenbolone on fecundity and reproductive endocrinology of the fathead minnow. Environ. Toxicol. Chem. 22, 1350-1360. (doi: 10. 1002/etc. 5620220623).
31. Ekman DR et al. 2011 Use of gene expression, biochemical and metabolite profiles to enhance exposure and effects assessment of the model androgen 17b-trenbolone in fish. Environ. Toxicol. Chem. 30, 319-329. (doi: 10. 1002/etc. 406).
32. Kiparissis Y, Metcalfe TL, Balch GC, Metcalfe CD. 2003 Effects of the antiandrogens, vinclozolin and cyproterone acetate on gonadal development in the Japanese medaka (Oryzias latipes). Aquat. Toxicol. 63, 391-403. (doi: 10. 1016/S0166-445X(02)00189-3).
33. Jensen KM, Kahl MD, Makynen EA, Korte JJ, Leino RL, Butterworth BC, Ankley GT. 2004 Characterization of responses to the antiandrogen flutamide in a short-term reproduction assay with the fathead minnow. Aquat. Toxicol. 70, 99-110. (doi: 10. 1016/j. aquatox. 2004. 06. 012).
34. Dey CJ, O'Connor CM, Gilmour KM, Van Der Kraak G, Cooke SJ. 2010 Behavioral and physiological responses of a wild teleost fish to cortisol and androgen manipulation during parental care. Horm. Behav. 58, 599-605. (doi: 10. 1016/j. yhbeh. 2010. 06. 016).
35. Nakamura A, Takanobu H, Tamura I, Yamamuro M, Iguchi T, Tatarazako N. 2013 Verification of responses of Japanese medaka (Oryzias latipes) to anti-androgens, vinclozolin and flutamide, in shortterm assays. J. Appl. Toxicol. 34, 545-553. (doi: 10. 1002/jat. 2934).
36. Hatef A, Alavi SM, Milla S, Kristan J, Golshan M, Fontaine P, Linhart O. 2012 Anti-androgen vinclozolin impairs sperm quality and steroidogenesis in goldfish. Aquat. Toxicol. 122-123, 181-187. (doi: 10. 1016/j. aquatox. 2012. 06. 009).
37. Martinovic D, Blake LS, Durhan EJ, Greene KJ, Kahl MD, Jensen KM, Makynen EA, Villeneuve DL, Ankley GT. 2008 Reproductive toxicity of vinclozolin in the fathead minnow: confirming an anti-androgenic mode of action. Environ. Toxicol. Chem. 27, 478-488. (doi: 10. 1897/07-206R. 1).
38. Sun L, Zha J, Spear PA, Wang Z. 2007 Tamoxifen effects on the early life stages and reproduction of Japanese medaka (Oryzias latipes). Environ. Toxicol. Pharmacol. 24, 23-29. (doi: 10. 1016/j. etap. 2007. 01. 003).
39. Sun L, Zha J, Wang Z. 2009 Effects of binary mixtures of estrogen and antiestrogens on Japanese medaka (Oryzias latipes). Aquat. Toxicol. 93, 83-89. (doi: 10. 1016/j. aquatox. 2009. 03. 010).
40. Singh R, Singh AK, Tripathi M. 2012 Effect of a non steroidal tamoxifen on the gonad and sex differentiation in Nile tilapia, Oreochromis niloticus. J. Environ. Biol. 33, 799-803.
41. Kitano T, Yoshinaga N, Shiraishi E, Koyanagi T, Abe S. 2007 Tamoxifen induces masculinization of genetic females and regulates P450 aromatase and Mullerian inhibiting substance mRNA expression in Japanese flounder (Paralichthys olivaceus). Mol. Reprod. Dev. 74, 1171-1177. (doi: 10. 1002/mrd. 20603).
42. Williams TD, Caunter JE, Lillicrap AD, Hutchinson TH, Gillings EG, Duffell S. 2007 Evaluation of the reproductive effects of tamoxifen citrate in partial and full life-cycle studies using fathead minnows (Pimephales promelas). Environ. Toxicol. Chem. 26, 695-707. (doi: 10. 1897/05-646R1. 1).
43. Zeilinger J, Steger-Hartmann T, Maser E, Goller S, Vonk R, Lange R. 2009 Effects of synthetic gestagens on fish reproduction. Environ. Toxicol. Chem. 28, 2663-2670. (doi: 10. 1897/08-485. 1).
44. Paulos P, Runnalls TJ, Nallani G, La Point T, Scott AP, Sumpter JP, Huggett DB. 2010 Reproductive responses in fathead minnow and Japanese medaka following exposure to a synthetic progestin, Norethindrone. Aquat. Toxicol. 99, 256-262. (doi: 10. 1016/j. aquatox. 2010. 05. 001).
45. Murack PJ, Parrish J, Barry TP. 2011 Effects of progesterone on sperm motility in fathead minnow (Pimephales promelas). Aquat. Toxicol. 104, 121-125. (doi: 10. 1016/j. aquatox. 2011. 04. 006).
46. DeQuattro ZA, Peissig EJ, Antkiewicz DS, Lundgren EJ, Hedman CJ, Hemming JD, Barry TP. 2012 Effects of progesterone on reproduction and embryonic development in the fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 31, 851-856. (doi: 10. 1002/etc. 1754).
47. LaLone CA et al. 2012 Effects of a glucocorticoid receptor agonist, dexamethasone, on fathead minnow reproduction, growth, and development. Environ. Toxicol. Chem. 31, 611-622. (doi: 10. 1002/etc. 1729).
48. Kugathas S, Sumpter JP. 2011 Synthetic glucocorticoids in the environment: first results on their potential impacts on fish. Environ. Sci. Technol. 45, 2377-2383. (doi: 10. 1021/es104105e).
49. Kugathas S, Runnalls TJ, Sumpter JP. 2013 Metabolic and reproductive effects of relatively low concentrations of beclomethasone dipropionate, a synthetic glucocorticoid, on fathead minnows. Environ. Sci. Technol. 47, 9487-9495. (doi: 10. 1021/es4019332).
50. Foran CM, Weston J, Slattery M, Brooks BW, Huggett DB. 2004 Reproductive assessment of Japanese medaka (Oryzias latipes) following a fourweek fluoxetine (SSRI) exposure. Arch. Environ. Contam. Toxicol. 46, 511-517. (doi: 10. 1007/s00244-003-3042-5).
51. Mennigen JA, Stroud P, Zamora JM, Moon TW, Trudeau VL. 2011 Pharmaceuticals as neuroendocrine disruptors: lessons learned from fish on Prozac. J. Toxicol. Environ. Health B Crit. Rev. 14, 387-412. (doi: 10. 1080/10937404. 2011. 578559).
52. Lister A, Regan C, Van Zwol J, Van Der Kraak G. 2009 Inhibition of egg production in zebrafish by fluoxetine and municipal effluents: a mechanistic evaluation. Aquat. Toxicol. 95, 320-329. (doi: 10. 1016/j. aquatox. 2009. 04. 011).
53. Painter MM, Buerkley MA, Julius ML, Vajda AM, Norris DO, Barber LB, Furlong ET, Schultz MM, Schoenfuss HL. 2009 Antidepressants at environmentally relevant concentrations affect predator avoidance behavior of larval fathead minnows (Pimephales promelas). Environ. Toxicol. Chem. 28, 2677-2684. (doi: 10. 1897/08-556. 1).
54. Schultz MM, Painter MM, Bartell SE, Logue A, Furlong ET, Werner SL, Schoenfuss HL. 2011 Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows. Aquat. Toxicol. 104, 38-47. (doi: 10. 1016/j. aquatox. 2011. 03. 011).
55. Valenti TW, Gould GG, Berninger JP, Connors KA, Keele NB, Prosser KN, Brooks BW. 2012 Human therapeutic plasma levels of the selective serotonin reuptake inhibitor (SSRI) sertraline decrease serotonin reuptake transporter binding and shelterseeking behavior in adult male fathead minnows. Environ. Sci. Technol. 46, 2427-2435. (doi: 10. 1021/es204164b).
56. Brandao FP, Rodrigues S, Castro BB, Goncalves F, Antunes SC, Nunes B. 2013 Short-term effects of neuroactive pharmaceutical drugs on a fish species: biochemical and behavioural effects. Aquat. Toxicol. 144-145, 218-229. (doi: 10. 1016/j. aquatox. 2013. 10. 005).
57. Thomas MA, Klaper RD. 2012 Psychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autism. PLoS ONE 7, e32917. (doi: 10. 1371/journal. pone. 0032917).
58. Stepanova S, Praskova E, Chromcova L, Plhalova L, Prokes M, Blahova J, Svobodova Z. 2013 The effects of diclofenac on early life stages of common carp (Cyprinus carpio). Environ. Toxicol. Pharmacol. 35, 454-460. (doi: 10. 1016/j. etap. 2012. 09. 011).
59. van den Brandhof EJ, Montforts M. 2010 Fish embryo toxicity of carbamazepine, diclofenac and metoprolol. Ecotoxicol. Environ. Saf. 73, 1862-1866. (doi: 10. 1016/j. ecoenv. 2010. 08. 031).
60. Lee J, Ji K, Lim Kho Y, Kim P, Choi K. 2011 Chronic exposure to diclofenac on two freshwater cladocerans and Japanese medaka. Ecotoxicol. Environ. Saf. 74, 1216-1225. (doi: 10. 1016/j. ecoenv. 2011. 03. 014).
61. Skolness SY, Durhan EJ, Jensen KM, Kahl MD, Makynen EA, Villeneuve DL, Ankley GT. 2012 Effects of gemfibrozil on lipid metabolism, steroidogenesis, and reproduction in the fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 31, 2615-2624. (doi: 10. 1002/etc. 1989).
62. Winter MJ et al. 2008 Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas). Aquat. Toxicol. 86, 361-369. (doi: 10. 1016/j. aquatox. 2007. 11. 017).
63. Giltrow E, Eccles PD, Winter MJ, McCormack PJ, Rand-Weaver M, Hutchinson TH, Sumpter JP. 2009 Chronic effects assessment and plasma concentrations of the beta-blocker propranolol in fathead minnows (Pimephales promelas). Aquat. Toxicol. 95, 195-202. (doi: 10. 1016/j. aquatox. 2009. 09. 002).
64. Lorenzi V, Mehinto AC, Denslow ND, Schlenk D. 2012 Effects of exposure to the beta-blocker propranolol on the reproductive behavior and gene expression of the fathead minnow, Pimephales promelas. Aquat. Toxicol. 116-117, 8-15. (doi: 10. 1016/j. aquatox. 2012. 03. 001).
65. Ankley GT, Kahl MD, Jensen KM, Hornung MW, Korte JJ, Makynen EA, Leino RL. 2002 Evaluation of the aromatase inhibitor fadrozole in a short-term reproduction assay with the fathead minnow (Pimephales promelas). Toxicol. Sci. 67, 121-130. (doi: 10. 1093/toxsci/67. 1. 121).
66. Ankley GT et al. 2005 Effects of two fungicides with multiple modes of action on reproductive endocrine function in the fathead minnow (Pimephales promelas). Toxicol. Sci. 86, 300-308. (doi: 10. 1093/toxsci/kfi202).
67. Villeneuve DL et al. 2009 Direct effects, compensation, and recovery in female fathead minnows exposed to a model aromatase inhibitor. Environ. Health Perspect. 117, 624-631. (doi: 10. 1289/ehp. 11891).
68. Skolness SY et al. 2013 Propiconazole inhibits steroidogenesis and reproduction in the fathead minnow (Pimephales promelas). Toxicol. Sci. 132, 284-297. (doi: 10. 1093/toxsci/kft010).
69. Ankley GT, Cavallin JE, Durhan EJ, Jensen KM, Kahl MD, Makynen EA, Thomas LM, Wehmas LC, Villeneuve DL. 2012 A time-course analysis of effects of the steroidogenesis inhibitor ketoconazole on components of the hypothalamic-pituitary-gonadal axis of fathead minnows. Aquat. Toxicol. 114-115, 88-95. (doi: 10. 1016/j. aquatox. 2012. 02. 012).
70. Villeneuve DL et al. 2010 I. Effects of a dopamine receptor antagonist on fathead minnow, Pimephales promelas, reproduction. Ecotoxicol. Environ. Saf. 73, 472-477. (doi: 10. 1016/j. ecoenv. 2009. 09. 007).
71. Villeneuve DL et al. 2010 II: Effects of a dopamine receptor antagonist on fathead minnow dominance behavior and ovarian gene expression in the fathead minnow and zebrafish. Ecotoxicol. Environ. Saf. 73, 478-485. (doi: 10. 1016/j. ecoenv. 2009. 09. 018).
72. Sharma P, Patino R. 2013 Regulation of gonadal sex ratios and pubertal development by the thyroid endocrine system in zebrafish (Danio rerio). Gen. Comp. Endocrinol. 184, 111-119. (doi: 10. 1016/j. ygcen. 2012. 12. 018).
73. Liu YW, Chan WK. 2002 Thyroid hormones are important for embryonic to larval transitory phase in zebrafish. Differentiation 70, 36-45. (doi: 10. 1046/j. 1432-0436. 2002. 700104. x).
74. Raldua D, Babin PJ. 2009 Simple, rapid zebrafish larva bioassay for assessing the potential of chemical pollutants and drugs to disrupt thyroid gland function. Environ. Sci. Technol. 43, 6844-6850. (doi: 10. 1021/es9012454).
75. Crane HM, Pickford DB, Hutchinson TH, Brown JA. 2006 The effects of methimazole on development of the fathead minnow, Pimephales promelas, from embryo to adult. Toxicol. Sci. 93, 278-285. (doi: 10. 1093/toxsci/kfl063).
76. Ankley GT, Jensen KM, Kahl MD, Makynen EA, Blake LS, Greene KJ, Johnson RD, Villeneuve DL. 2007 Ketoconazole in the fathead minnow (Pimephales promelas): reproductive toxicity and biological compensation. Environ. Toxicol. Chem. 26, 1214-1223. (doi: 10. 1897/06-428R. 1).
77. University of Hertfordshire. 2013 The veterinary substance database (VSDB) developed by the Agriculture and Environment Research Unit (AERU). http://sitem. herts. ac. uk/aeru/vsdb/.
78. Panter GH, Glennon YC, Robinson J, Hargreaves A, Murray-Smith R. 2012 Effects of the anti-androgen, bicalutamide, in a reduced life-cycle study with the fathead minnow (Pimephales promelas). Aquat. Toxicol. 114-115, 31-38. (doi: 10. 1016/j. aquatox. 2012. 02. 002).
79. Martyniuk CJ, Bissegger S, Langlois VS. 2013 Current perspectives on the androgen 5a-dihydrotestosterone (DHT) and 5a-reductases in teleost fishes and amphibians. Gen. Comp. Endocrinol. 194, 264-274. (doi: 10. 1016/j. ygcen. 2013. 09. 019).
80. Runnalls TJ, Beresford N, Losty E, Scott AP, Sumpter JP. 2013 Several synthetic progestins with different potencies adversely affect reproduction of fish. Environ. Sci. Technol. 47, 2077-2084. (doi: 10. 1021/es3048834).
81. Svensson J, Fick J, Brandt I, Brunstrom B. 2013 The synthetic progestin levonorgestrel is a potent androgen in the three-spined stickleback (Gasterosteus aculeatus). Environ. Sci. Technol. 47, 2043-2051. (doi: 10. 1021/es304305k).
82. Rivero-Wendt CL, Miranda-Vilela AL, Ferreira MF, Borges AM, Grisolia CK. 2013 Cytogenetic toxicity and gonadal effects of 17a-methyltestosterone in Astyanax bimaculatus (Characidae) and Oreochromis niloticus (Cichlidae). Genet. Mol. Res. 12, 3862-3870. (doi: 10. 4238/2013. September. 23. 4).
83. Sanchez-Hernandez M, Chaves-Pozo E, Cabas I, Mulero V, Garcia-Ayala A, Garcia-Alcazar A. 2013 Testosterone implants modify the steroid hormone balance and the gonadal physiology of gilthead seabream (Sparus aurata L.) males. J. Steroid Biochem. Mol. Biol. 138, 183-194. (doi: 10. 1016/j. jsbmb. 2013. 05. 014).
84. Tousson E, El-Moghazy M, Massoud A, El-Atrash E, Sweef O, Akel A. 2013 Physiological and biochemical changes after boldenone injection in adult rabbits. Toxicol. Ind. Health Epub ahead of print. (doi: 10. 1177/0748233713501365).
85. Nieschlag E, Kumar N, Sitruk-Ware R. 2013 7a-Methyl-19-nortestosterone (MENTR): the population council's contribution to research on male contraception and treatment of hypogonadism. Contraception 87, 288-295. (doi: 10. 1016/j. contraception. 2012. 08. 036).
86. Perkins EJ, Ankley GT, Crofton KM, Garcia-Reyero N, LaLone CA, Johnson MS, Tietge JE, Villeneuve DL. 2013 Current perspectives on the use of alternative species in human health and ecological hazard assessments. Environ. Health Perspect. 121, 1002-1010. (doi: 10. 1289/ehp. 1306638).
87. Huggett DB, Cook JC, Ericson JF, Williams RT. 2003 A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum. Ecol. Risk Assess. 9, 1789-1799. (doi: 10. 1080/714044797).
88. Caldwell Dj, Mastrocco F, Margiotta-Casaluci L, Brooks BW. In press. An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research. Chemosphere (doi: 10. 1016/j. chemosphere. 2014. 01. 021).
89. Diamond JM, Latimer HA, Munkittrick KR, Thornton KW, Bartell SM, Kidd KA. 2011 Prioritizing contaminants of emerging concern for ecological screening assessments. Environ. Toxicol. Chem. 30, 2385-2394. (doi: 10. 1002/etc. 667).
90. Connors KA, Du B, Fitzsimmons PN, Hoffman AD, Chambliss CK, Nichols JW, Brooks BW. 2013 Comparative pharmaceutical metabolism by rainbow trout (Oncorhynchus mykiss) liver S9 fractions. Environ. Toxicol. Chem. 32, 1810-1818. (doi: 10. 1002/etc. 2240).
91. Hutchinson TH, Madden JC, Naidoo V, Walker CH. 2014 Comparative metabolism as a key driver of wildlife species sensitivity to human and veterinary pharmaceuticals. Phil. Trans. R. Soc. B 369, 20130583. (doi: 10. 1098/rstb. 2013. 0583).
92. Brown AR, Gunnarsson L, Kristiansson E, Tyler CR. 2014 Assessing variation in the potential susceptibility of fish to pharmaceuticals, considering evolutionary differences in their physiology and ecology. Phil. Trans. R. Soc. B 369, 20130576. (doi: 10. 1098/rstb. 2013. 0576).